Schubert, Marc Cicero http://orcid.org/0000-0003-1077-1848
Soyka, Stella Judith http://orcid.org/0000-0002-8070-8951
Tamimi, Amr http://orcid.org/0000-0001-6873-4471
Maus, Emanuel http://orcid.org/0000-0003-3898-866X
Schroers, Julian http://orcid.org/0009-0001-9838-4801
Wißmann, Niklas http://orcid.org/0000-0002-4038-3232
Reyhan, Ekin http://orcid.org/0000-0002-2109-0186
Tetzlaff, Svenja Kristin http://orcid.org/0000-0002-2893-920X
Yang, Yvonne http://orcid.org/0000-0001-7116-6911
Denninger, Robert
Peretzke, Robin
Beretta, Carlo
Drumm, Michael
Heuer, Alina
Buchert, Verena
Steffens, Alicia
Walshon, Jordain
McCortney, Kathleen http://orcid.org/0000-0001-7085-830X
Heiland, Sabine
Bendszus, Martin
Neher, Peter http://orcid.org/0000-0002-5285-7554
Golebiewska, Anna http://orcid.org/0000-0002-4160-2521
Wick, Wolfgang http://orcid.org/0000-0002-6171-634X
Winkler, Frank
Breckwoldt, Michael O. http://orcid.org/0000-0002-9980-2390
Kreshuk, Anna http://orcid.org/0000-0003-1334-6388
Kuner, Thomas http://orcid.org/0000-0003-1896-9031
Horbinski, Craig http://orcid.org/0000-0001-8340-9992
Kurz, Felix Tobias
Prevedel, Robert http://orcid.org/0000-0003-3366-4703
Venkataramani, Varun http://orcid.org/0000-0002-2927-0886
Article History
Received: 4 December 2023
Accepted: 7 August 2024
First Online: 10 September 2024
Competing interests
: F.W. and W.W. report the patent (WO2017020982A1) “Agents for use in the treatment of glioma.” F.W. is co-founder of DC Europa Ltd (a company trading under the name Divide & Conquer) that is developing new medicines for the treatment of glioma. Divide & Conquer also provides research funding to F.W.’s lab under a research collaboration agreement. The remaining authors declare no competing interests.